Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review.

Yadava Srikanth, Dontiboina Harikrishna Reddy, Vinjavarapu Lakshmi Anusha, Naresh Dumala, Matte Kasi Viswanadh, Guntupalli Chakravarthi, Buchi N Nalluri, Ganesh Yadagiri, Kakarla Ramakrishna
Author Information
  1. Yadava Srikanth: KL College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram 522302, India. ORCID
  2. Dontiboina Harikrishna Reddy: KL College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram 522302, India.
  3. Vinjavarapu Lakshmi Anusha: KL College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram 522302, India.
  4. Naresh Dumala: KL College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram 522302, India. ORCID
  5. Matte Kasi Viswanadh: KL College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram 522302, India.
  6. Guntupalli Chakravarthi: KL College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram 522302, India.
  7. Buchi N Nalluri: KL College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram 522302, India.
  8. Ganesh Yadagiri: Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. ORCID
  9. Kakarla Ramakrishna: KL College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram 522302, India. ORCID

Abstract

Cruciferae family vegetables are remarkably high in phytochemicals such as Indole-3-carbinol (I3C) and Diindolylmethane (DIM), which are widely known as nutritional supplements. I3C and DIM have been studied extensively in different types of cancers like breast, prostate, endometrial, colorectal, gallbladder, hepatic, and cervical, as well as cancers in other tissues. In this review, we summarized the protective effects of I3C and DIM against cardiovascular, neurological, reproductive, metabolic, bone, respiratory, liver, and immune diseases, infections, and drug- and radiation-induced toxicities. Experimental evidence suggests that I3C and DIM offer protection due to their antioxidant, anti-inflammatory, antiapoptotic, immunomodulatory, and xenobiotic properties. Apart from the beneficial effects, the present review also discusses the possible toxicities of I3C and DIM that are reported in various preclinical investigations. So far, most of the reports about I3C and DIM protective effects against various diseases are only from preclinical studies; this emphasizes the dire need for large-scale clinical trials on these phytochemicals against human diseases. Further, in-depth research is required to improve the bioavailability of these two phytochemicals to achieve the desirable protective effects. Overall, our review emphasizes that I3C and DIM may become potential drug candidates for combating dreadful human diseases.

Keywords

References

  1. Clin Immunol. 2009 Jun;131(3):481-94 [PMID: 19278904]
  2. Int J Dev Neurosci. 2023 Feb;83(1):31-43 [PMID: 36259087]
  3. J Neuroimmunol. 2020 Feb 20;342:577195 [PMID: 32120083]
  4. Chem Res Toxicol. 1992 Mar-Apr;5(2):188-93 [PMID: 1643248]
  5. Breast Cancer Res Treat. 2017 Aug;165(1):97-107 [PMID: 28560655]
  6. Folia Biol (Praha). 1980;26(5):289-97 [PMID: 7439464]
  7. Front Immunol. 2024 Mar 26;15:1330373 [PMID: 38596679]
  8. J Neuroinflammation. 2017 Sep 18;14(1):187 [PMID: 28923114]
  9. Int J Obes (Lond). 2013 Jun;37(6):881-4 [PMID: 22986685]
  10. Lett Appl Microbiol. 2023 Aug 2;76(8): [PMID: 37580156]
  11. Microbiol Spectr. 2022 Feb 23;10(1):e0205621 [PMID: 35107361]
  12. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Apr 25;787(2):281-91 [PMID: 12650751]
  13. J Surg Res. 2017 Jul;215:34-46 [PMID: 28688659]
  14. Biochem Pharmacol. 2024 May;223:116193 [PMID: 38582268]
  15. PLoS One. 2012;7(4):e34957 [PMID: 22506059]
  16. Arq Bras Cardiol. 2016 Jan;106(1):62-9 [PMID: 26647721]
  17. Eur J Pharmacol. 2022 Mar 15;919:174812 [PMID: 35151647]
  18. Colloids Surf B Biointerfaces. 2019 Sep 1;181:295-304 [PMID: 31154140]
  19. FEBS J. 2007 Dec;274(24):6415-25 [PMID: 18028426]
  20. Phytother Res. 2024 Mar;38(3):1381-1399 [PMID: 38217095]
  21. J Hypertens. 2009 Mar;27(3):575-86 [PMID: 19330918]
  22. Drug Metabol Drug Interact. 2000;17(1-4):159-88 [PMID: 11201294]
  23. Neural Regen Res. 2017 Jan;12(1):7-12 [PMID: 28250730]
  24. Acta Biochim Pol. 2007;54(1):113-7 [PMID: 17311112]
  25. Front Mol Neurosci. 2024 Nov 28;17:1499591 [PMID: 39669439]
  26. Toxicol Ind Health. 2014 May;30(4):357-75 [PMID: 22914261]
  27. Biochimie. 2014 Sep;104:127-36 [PMID: 24952351]
  28. Curr Drug Metab. 2001 Jun;2(2):149-64 [PMID: 11469723]
  29. Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2477-81 [PMID: 17164373]
  30. Antimicrob Agents Chemother. 2009 Jun;53(6):2589-98 [PMID: 19332675]
  31. Eur J Med Chem. 2020 May 15;194:112245 [PMID: 32220687]
  32. Int J Cardiol. 2014 Apr 1;172(3):e531-3 [PMID: 24507738]
  33. J Toxicol Environ Health A. 2000 Feb 25;59(4):271-9 [PMID: 10706034]
  34. Ann Pharm Fr. 2025 Mar;83(2):228-250 [PMID: 39159826]
  35. World J Gastroenterol. 2013 Jun 21;19(23):3534-42 [PMID: 23801854]
  36. Front Physiol. 2020 Oct 30;11:578966 [PMID: 33192583]
  37. Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18355-6 [PMID: 24187150]
  38. Molecules. 2019 Dec 06;24(24): [PMID: 31817632]
  39. Clin Exp Pharmacol Physiol. 2010 Dec;37(12):1107-13 [PMID: 20880187]
  40. J Hypertens. 2011 Dec;29(12):2369-80 [PMID: 22025236]
  41. Nutr Res Rev. 2010 Dec;23(2):270-99 [PMID: 20977819]
  42. Am J Physiol Renal Physiol. 2007 Nov;293(5):F1584-91 [PMID: 17715265]
  43. Neurochem Int. 2024 Oct;179:105823 [PMID: 39084351]
  44. Nutr Cancer. 2003;45(1):101-12 [PMID: 12791510]
  45. Biochem Pharmacol. 2010 Mar 1;79(5):715-21 [PMID: 19854159]
  46. Chem Biol Interact. 1991;80(3):303-15 [PMID: 1954658]
  47. Birth Defects Res B Dev Reprod Toxicol. 2005 Jun;74(3):261-7 [PMID: 15954085]
  48. Diseases. 2024 Aug 16;12(8): [PMID: 39195183]
  49. J Am Soc Nephrol. 2012 Mar;23(3):405-11 [PMID: 22193383]
  50. Biochimie. 2023 Oct;213:1-11 [PMID: 37120006]
  51. Biochem Biophys Res Commun. 2015 May 1;460(2):422-7 [PMID: 25795137]
  52. Res Pharm Sci. 2012 Jul;7(3):159-69 [PMID: 23181094]
  53. Am J Pathol. 1998 Aug;153(2):587-98 [PMID: 9708818]
  54. Front Immunol. 2019 Jul 23;10:1620 [PMID: 31396207]
  55. J Hypertens. 2011 Nov;29(11):2126-37 [PMID: 21946693]
  56. Br J Pharmacol. 2013 Oct;170(3):649-60 [PMID: 23902531]
  57. Mediators Inflamm. 2010;2010:293642 [PMID: 20414337]
  58. Acta Pharm Sin B. 2019 Mar;9(2):369-380 [PMID: 30972283]
  59. J Fungi (Basel). 2021 Jan 22;7(2): [PMID: 33499276]
  60. J Nutr Biochem. 2018 May;55:12-25 [PMID: 29331880]
  61. J Infect Chemother. 2016 Jan;22(1):36-43 [PMID: 26603425]
  62. Am J Physiol Renal Physiol. 2005 Apr;288(4):F810-5 [PMID: 15585671]
  63. Int J Radiat Biol. 2018 Jun;94(6):558-568 [PMID: 29671693]
  64. Sci Rep. 2024 Feb 7;14(1):3145 [PMID: 38326384]
  65. Int J Obes (Lond). 2011 Dec;35(12):1530-8 [PMID: 21343904]
  66. Front Pharmacol. 2022 Feb 15;13:829966 [PMID: 35242039]
  67. Antioxid Redox Signal. 2013 Nov 10;19(14):1711-47 [PMID: 23305298]
  68. Tumour Biol. 2017 Mar;39(3):1010428317695923 [PMID: 28347231]
  69. Nutrients. 2023 Nov 30;15(23): [PMID: 38068838]
  70. Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18650-5 [PMID: 24127581]
  71. Life Sci. 2023 Aug 1;326:121796 [PMID: 37230378]
  72. Toxicol Appl Pharmacol. 2022 Jan 15;435:115853 [PMID: 34973289]
  73. Am J Physiol Renal Physiol. 2007 Jun;292(6):F1858-66 [PMID: 17344186]
  74. Nat Neurosci. 2007 Sep;10(9):1089-93 [PMID: 17726474]
  75. Int J Mol Sci. 2021 Feb 07;22(4): [PMID: 33562271]
  76. Pharmaceuticals (Basel). 2024 Dec 11;17(12): [PMID: 39770511]
  77. mBio. 2023 Apr 25;14(2):e0313722 [PMID: 36809070]
  78. Toxicol Lett. 2011 Oct 10;206(2):218-28 [PMID: 21820497]
  79. Mutat Res. 2011 Jul-Oct;728(1-2):47-66 [PMID: 21703360]
  80. Arch Pediatr Adolesc Med. 2007 Oct;161(10):951-8 [PMID: 17909138]
  81. Case Rep Med. 2016;2016:7527098 [PMID: 28050169]
  82. Am J Transl Res. 2010 Jul 23;2(4):402-11 [PMID: 20733950]
  83. Apoptosis. 2020 Oct;25(9-10):747-762 [PMID: 32816128]
  84. Med Chem. 2017;13(8):727-733 [PMID: 28934926]
  85. Obesity (Silver Spring). 2018 Jul;26(7):1153-1160 [PMID: 29722480]
  86. Biomol Biomed. 2023 Nov 03;23(6):936-948 [PMID: 37337893]
  87. Biofilm. 2021 Dec 09;4:100063 [PMID: 34950868]
  88. Pharmaceuticals (Basel). 2023 Feb 05;16(2): [PMID: 37259386]
  89. Vaccines (Basel). 2017 Oct 04;5(4): [PMID: 28976923]
  90. Phytomedicine. 2024 Jul;129:155621 [PMID: 38678950]
  91. J Environ Pathol Toxicol Oncol. 2004;23(3):215-26 [PMID: 15312044]
  92. J Pharmacol Exp Ther. 2016 Apr;357(1):177-87 [PMID: 26818958]
  93. J Agric Food Chem. 2016 Oct 19;64(41):7702-7709 [PMID: 27700072]
  94. Food Res Int. 2023 Dec;174(Pt 1):113513 [PMID: 37986509]
  95. Life Sci. 2021 Jun 15;275:119361 [PMID: 33774022]
  96. Phytother Res. 2008 Jan;22(1):58-64 [PMID: 17724769]
  97. Nat Prod Bioprospect. 2024 Jul 30;14(1):42 [PMID: 39078427]
  98. Parasite Epidemiol Control. 2022 Feb 16;17:e00244 [PMID: 35243049]
  99. PLoS One. 2017 Jun 30;12(6):e0180321 [PMID: 28666018]
  100. Toxicol Pathol. 2012 Jun;40(4):561-76 [PMID: 22328411]
  101. Pharmacol Res. 2005 May;51(5):391-8 [PMID: 15749453]
  102. Chin Med. 2024 Dec 26;19(1):177 [PMID: 39722037]
  103. Toxins (Basel). 2010 Nov;2(11):2490-518 [PMID: 22069563]
  104. Yao Xue Xue Bao. 2011 Aug;46(8):915-21 [PMID: 22007515]
  105. Biochem Biophys Rep. 2023 Jun 01;35:101492 [PMID: 37304131]
  106. Pathogens. 2021 Oct 12;10(10): [PMID: 34684258]
  107. Cell Microbiol. 2014 Oct;16(10):1484-92 [PMID: 25073615]
  108. Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):281-6 [PMID: 16101534]
  109. J Hypertens. 2006 Dec;24(12):2465-72 [PMID: 17082731]
  110. Neuropharmacology. 2021 Apr 1;187:108490 [PMID: 33607146]
  111. J Gastrointest Surg. 2022 Mar;26(3):671-683 [PMID: 34734369]
  112. Theranostics. 2017 Apr 10;7(6):1674-1688 [PMID: 28529644]
  113. 3 Biotech. 2025 Feb;15(2):51 [PMID: 39898236]
  114. Neuroscience. 2025 Jan 26;565:527-547 [PMID: 39681254]
  115. Int J Mol Sci. 2020 Dec 17;21(24): [PMID: 33348908]
  116. J Pharmacol Exp Ther. 2013 Apr;345(1):125-38 [PMID: 23318470]
  117. Mol Neurobiol. 2016 Oct;53(8):5591-606 [PMID: 26476840]
  118. Adv Pharmacol Sci. 2014;2014:832161 [PMID: 24982671]
  119. Nat Rev Mol Cell Biol. 2008 May;9(5):367-77 [PMID: 18401346]
  120. Biochem J. 2008 Jan 15;409(2):611-22 [PMID: 17922678]
  121. Arab J Gastroenterol. 2018 Jun;19(2):56-64 [PMID: 29853428]
  122. Br J Pharmacol. 2015 Apr;172(8):2133-47 [PMID: 25521277]
  123. Cancers (Basel). 2011 Jul 19;3(3):2955-74 [PMID: 24212940]
  124. Environ Health Perspect. 1999 May;107(5):377-84 [PMID: 10210693]
  125. J Clin Microbiol. 1994 Oct;32(10):2494-500 [PMID: 7814488]
  126. Int J Mol Sci. 2021 Dec 30;23(1): [PMID: 35008822]
  127. Pflugers Arch. 2017 Apr;469(3-4):365-374 [PMID: 28185068]
  128. Toxicol Lett. 2015 Feb 3;232(3):580-9 [PMID: 25542144]
  129. Alcohol. 2002 May;27(1):63-8 [PMID: 12062639]
  130. Mol Nutr Food Res. 2017 Oct;61(10): [PMID: 28586165]
  131. South Med J. 2012 Dec;105(12):650-6 [PMID: 23211499]
  132. Vascul Pharmacol. 2009 May-Jun;50(5-6):194-9 [PMID: 19563737]
  133. Sci Rep. 2016 Jul 15;6:29857 [PMID: 27417335]
  134. Int J Mol Sci. 2020 Mar 17;21(6): [PMID: 32192079]
  135. Apoptosis. 2019 Jun;24(5-6):435-452 [PMID: 30778709]
  136. Ann Hepatol. 2019 Sep - Oct;18(5):765-769 [PMID: 31105018]
  137. EPMA J. 2016 Apr 02;7:5 [PMID: 27042242]
  138. Neurotherapeutics. 2010 Oct;7(4):354-65 [PMID: 20880500]
  139. Int J Clin Exp Pathol. 2015 May 01;8(5):5121-8 [PMID: 26191207]
  140. Mol Nutr Food Res. 2017 Sep;61(9): [PMID: 28267258]
  141. Cell Cycle. 2005 Sep;4(9):1201-15 [PMID: 16082211]
  142. Antioxidants (Basel). 2019 Dec 18;9(1): [PMID: 31861353]
  143. Nat Prod Res. 2022 Dec;36(23):6044-6049 [PMID: 35175868]
  144. J Neuroinflammation. 2020 Nov 3;17(1):327 [PMID: 33143743]
  145. Reprod Toxicol. 2014 Jan;43:56-66 [PMID: 24257414]
  146. Med Rev (2021). 2022 Nov 22;2(6):590-610 [PMID: 37724254]
  147. Mol Nutr Food Res. 2013 Sep;57(9):1680-7 [PMID: 23625645]
  148. Free Radic Biol Med. 2019 Jan;130:244-255 [PMID: 30352304]
  149. IUBMB Life. 2007 Jun;59(6):408-12 [PMID: 17613172]
  150. J Affect Disord. 2023 May 15;329:207-217 [PMID: 36842647]
  151. Arch Dis Child Fetal Neonatal Ed. 2006 Nov;91(6):F454-9 [PMID: 17056843]
  152. Toxicol Appl Pharmacol. 2006 Mar 1;211(2):115-23 [PMID: 16043203]
  153. Food Chem Toxicol. 2013 Jul;57:256-61 [PMID: 23597448]
  154. Theranostics. 2023 Jan 1;13(1):417-437 [PMID: 36593958]
  155. Diseases. 2023 Jun 25;11(3): [PMID: 37489441]
  156. Ann Surg. 2017 Jun;265(6):1183-1191 [PMID: 27280500]
  157. J Biol Chem. 2003 Feb 7;278(6):3521-6 [PMID: 12444094]
  158. FASEB J. 1990 Oct;4(13):3076-86 [PMID: 2210154]
  159. Biol Pharm Bull. 2008 Sep;31(9):1798-801 [PMID: 18758080]
  160. In Vivo. 2010 Jul-Aug;24(4):387-91 [PMID: 20668304]
  161. Free Radic Res. 2024 May-Jun;58(6-7):367-379 [PMID: 38962912]
  162. Hum Exp Toxicol. 2004 May;23(5):245-50 [PMID: 15222402]
  163. J Affect Disord. 2022 Jul 15;309:201-210 [PMID: 35461819]
  164. J Hypertens. 2008 Jan;26(1):102-9 [PMID: 18090546]
  165. Eur J Drug Metab Pharmacokinet. 2022 Jul;47(4):593-605 [PMID: 35482227]
  166. Biomed Pharmacother. 2018 May;101:228-243 [PMID: 29494960]
  167. Mol Cancer Ther. 2007 Nov;6(11):3071-9 [PMID: 18025290]
  168. Biochem Pharmacol. 1994 Jan 20;47(2):359-64 [PMID: 8304980]
  169. Food Chem Toxicol. 1989 May;27(5):289-93 [PMID: 2473016]
  170. J Toxicol Sci. 2013;38(4):611-7 [PMID: 23824016]
  171. J Nutr. 2008 Jan;138(1):17-23 [PMID: 18156398]
  172. PLoS One. 2011;6(12):e28493 [PMID: 22174820]
  173. Chem Biol Interact. 2017 Aug 1;273:190-199 [PMID: 28619389]
  174. Cell Physiol Biochem. 2017;41(4):1481-1490 [PMID: 28395284]
  175. Int J Mol Sci. 2016 Aug 03;17(8): [PMID: 27527145]
  176. Inflamm Bowel Dis. 2009 Aug;15(8):1164-73 [PMID: 19334074]
  177. J Am Coll Cardiol. 2000 Mar 1;35(3):569-82 [PMID: 10716457]
  178. Cell Death Discov. 2022 Dec 15;8(1):491 [PMID: 36522315]
  179. Exp Neurol. 2021 Jan;335:113518 [PMID: 33144066]
  180. Cancer Lett. 2008 Apr 18;262(2):153-63 [PMID: 18314259]
  181. Free Radic Biol Med. 2016 Oct;99:463-471 [PMID: 27609226]
  182. Adv Exp Med Biol. 2017;1027:21-37 [PMID: 29063428]
  183. Neurotoxicology. 2014 Sep;44:48-57 [PMID: 24877722]
  184. J Nutr Biochem. 2008 May;19(5):336-44 [PMID: 17707631]
  185. J Mol Recognit. 2024 Nov;37(6):e3101 [PMID: 39221493]
  186. Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1026-1036 [PMID: 28130199]
  187. Respir Med. 2017 May;126:116-121 [PMID: 28427542]
  188. Free Radic Res. 2017 Oct;51(9-10):812-827 [PMID: 28922986]
  189. Circulation. 2021 Aug 31;144(9):694-711 [PMID: 34139860]
  190. Metabolites. 2012 Apr 16;2(2):303-36 [PMID: 24957513]
  191. BMC Complement Altern Med. 2018 Dec 19;18(1):337 [PMID: 30567538]
  192. Otolaryngol Head Neck Surg. 1998 Jun;118(6):810-5 [PMID: 9627242]
  193. Front Neurosci. 2015 Dec 16;9:469 [PMID: 26733784]
  194. Int J Mol Sci. 2019 Jan 08;20(1): [PMID: 30626076]
  195. J Natl Cancer Inst. 2010 Jan 6;102(1):14-25 [PMID: 20007921]
  196. Oxid Med Cell Longev. 2010 May-Jun;3(3):178-85 [PMID: 20716942]
  197. Circ Res. 2016 May 27;118(11):1723-35 [PMID: 27230638]
  198. Cell Immunol. 2020 Dec;358:104238 [PMID: 33137648]
  199. Curr Top Microbiol Immunol. 2016;398:3-33 [PMID: 27406189]
  200. J Nutr Biochem. 2013 Jan;24(1):62-9 [PMID: 22784431]
  201. Curr Neurovasc Res. 2022;19(5):462-475 [PMID: 36397630]
  202. Life (Basel). 2023 Jun 20;13(6): [PMID: 37374202]
  203. J Med Food. 2017 Jul;20(7):646-652 [PMID: 28459610]
  204. Reprod Toxicol. 2018 Aug;79:96-123 [PMID: 29925041]
  205. Gynecol Oncol. 2000 Aug;78(2):123-9 [PMID: 10926790]
  206. Toxicol Sci. 2014 Jan;137(1):158-67 [PMID: 24162184]
  207. J Physiol Biochem. 2014 Jun;70(2):525-34 [PMID: 24715233]
  208. Acta Pharm Sin B. 2021 Dec;11(12):3857-3868 [PMID: 35024312]
  209. Arthritis Rheumatol. 2018 Apr;70(4):496-507 [PMID: 29207444]
  210. Biochem Pharmacol. 2024 Dec;230(Pt 3):116618 [PMID: 39528071]
  211. Lancet Neurol. 2020 Mar;19(3):255-265 [PMID: 31813850]
  212. Int J Mol Sci. 2024 Feb 18;25(4): [PMID: 38397081]
  213. Chronic Stress (Thousand Oaks). 2022 Feb 8;6:24705470221076390 [PMID: 35155966]
  214. Biochem Pharmacol. 1988 Jan 15;37(2):333-8 [PMID: 3342090]
  215. Mol Med Rep. 2015 Jul;12(1):1247-52 [PMID: 25816057]
  216. Toxicol Lett. 1999 Jun 1;106(2-3):137-41 [PMID: 10403657]
  217. Clin Cancer Res. 2004 Aug 1;10(15):5233-41 [PMID: 15297427]
  218. Front Pharmacol. 2025 Jan 03;15:1499142 [PMID: 39830328]
  219. Int J Cancer. 2004 Oct 10;111(6):961-7 [PMID: 15300810]
  220. BMJ Case Rep. 2017 Jun 8;2017: [PMID: 28596204]
  221. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9543-7 [PMID: 1658785]
  222. Food Chem Toxicol. 1994 Jul;32(7):633-9 [PMID: 8045476]
  223. Am J Trop Med Hyg. 2005 Jun;72(6):819-24 [PMID: 15964970]
  224. Nat Rev Gastroenterol Hepatol. 2016 Nov;13(11):654-664 [PMID: 27580687]
  225. Mol Cell Biochem. 2024 May;479(5):1121-1132 [PMID: 37310587]
  226. Nature. 2006 Dec 14;444(7121):847-53 [PMID: 17167472]
  227. EMBO Mol Med. 2019 Feb;11(2): [PMID: 30591521]
  228. Toxicology. 2023 Jun 15;492:153542 [PMID: 37150287]
  229. Biochemistry. 2006 Apr 18;45(15):4727-35 [PMID: 16605241]
  230. Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Nov;1862(11):1451-1460 [PMID: 27760389]
  231. Neurochem Int. 2015 Aug;87:92-105 [PMID: 26055970]
  232. Pharmaceutics. 2022 Apr 30;14(5): [PMID: 35631553]
  233. PLoS One. 2015 Feb 23;10(2):e0118506 [PMID: 25706292]
  234. J Microencapsul. 2020 Nov;37(7):528-541 [PMID: 32852233]
  235. J Nanosci Nanotechnol. 2015 Oct;15(10):7922-8 [PMID: 26726441]
  236. Naunyn Schmiedebergs Arch Pharmacol. 2020 Mar;393(3):429-444 [PMID: 31654086]
  237. Nutr Cancer. 2001;41(1-2):57-63 [PMID: 12094629]
  238. Biomed Pharmacother. 2021 Jul;139:111708 [PMID: 34243633]
  239. Clin Microbiol Rev. 2004 Oct;17(4):794-803, table of contents [PMID: 15489349]
  240. ACS Omega. 2025 Feb 10;10(6):5963-5972 [PMID: 39989805]
  241. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1953-60 [PMID: 16103443]
  242. Annu Rev Food Sci Technol. 2023 Mar 27;14:347-366 [PMID: 36972159]
  243. Jpn Dent Sci Rev. 2021 Nov;57:201-208 [PMID: 34703508]
  244. Naunyn Schmiedebergs Arch Pharmacol. 2018 Jun;391(6):613-625 [PMID: 29602953]
  245. Microbiome. 2025 Feb 4;13(1):36 [PMID: 39905483]
  246. Phytochemistry. 2023 Aug;212:113713 [PMID: 37169138]
  247. Pharmaceuticals (Basel). 2024 Nov 24;17(12): [PMID: 39770419]
  248. Biol Pharm Bull. 2007 Oct;30(10):1865-9 [PMID: 17917252]
  249. J Nutr. 2007 Oct;137(10):2185-9 [PMID: 17884995]
  250. Front Nutr. 2025 Feb 19;12:1500293 [PMID: 40046764]
  251. Eur J Pharm Sci. 2020 Aug 1;151:105379 [PMID: 32473199]
  252. Exp Mol Pathol. 1987 Apr;46(2):180-9 [PMID: 3556531]
  253. J Immunotoxicol. 2017 Dec;14(1):228-234 [PMID: 29179596]
  254. J Nutr. 2003 Jul;133(7 Suppl):2470S-2475S [PMID: 12840226]
  255. J Vector Borne Dis. 2025 Feb 15;: [PMID: 39953857]
  256. Curr Drug Metab. 2016;17(4):401-9 [PMID: 26651978]
  257. J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021 [PMID: 33309175]
  258. Mol Cell Biochem. 2014 Jan;385(1-2):7-15 [PMID: 24072613]
  259. Indian J Dermatol Venereol Leprol. 2017 Jul-Aug;83(4):415-423 [PMID: 28195077]
  260. Eur J Med Chem. 2023 Nov 5;259:115670 [PMID: 37515920]
  261. Brain Behav Immun. 2020 Nov;90:108-137 [PMID: 32800927]
  262. Arch Toxicol. 1991;65(2):81-94 [PMID: 1711838]
  263. Bioorg Chem. 2019 Jul;88:102925 [PMID: 31003078]
  264. Eur J Pharm Sci. 2018 Jan 1;111:133-141 [PMID: 28966097]
  265. Eur J Inflamm. 2012 Sep;10(3):335-346 [PMID: 33024444]
  266. Vopr Pitan. 2013;82(2):23-30 [PMID: 24000696]
  267. J Nutr Biochem. 2012 Dec;23(12):1732-9 [PMID: 22569347]
  268. Biomed Res Int. 2017;2017:4863079 [PMID: 28286764]
  269. Rheumatology (Oxford). 2008 May;47(5):584-90 [PMID: 18234712]
  270. Neurotherapeutics. 2025 Mar;22(2):e00531 [PMID: 39909809]
  271. Toxicol Appl Pharmacol. 2016 Jul 15;303:101-109 [PMID: 27178563]
  272. Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:279-286 [PMID: 28254296]
  273. Viral Immunol. 2015 Sep;28(7):354-9 [PMID: 26086678]
  274. J Voice. 2004 Jun;18(2):248-53 [PMID: 15193659]
  275. Ther Adv Cardiovasc Dis. 2016 Jun;10(3):162-71 [PMID: 27105891]
  276. Int J Med Sci. 2012;9(3):193-9 [PMID: 22408567]

Grants

  1. EEQ/2023/000766/Science and Engineering Research Board (SERB), Government of India.

Word Cloud

Created with Highcharts 10.0.0I3CDIMeffectsdiseasesphytochemicalsreviewprotectivevegetablescancerstoxicitiesprotectionantioxidantvariouspreclinicalemphasizeshumanCruciferaefamilyremarkablyhighIndole-3-carbinolDiindolylmethanewidelyknownnutritionalsupplementsstudiedextensivelydifferenttypeslikebreastprostateendometrialcolorectalgallbladderhepaticcervicalwelltissuessummarizedcardiovascularneurologicalreproductivemetabolicbonerespiratoryliverimmuneinfectionsdrug-radiation-inducedExperimentalevidencesuggestsofferdueanti-inflammatoryantiapoptoticimmunomodulatoryxenobioticpropertiesApartbeneficialpresentalsodiscussespossiblereportedinvestigationsfarreportsstudiesdireneedlarge-scaleclinicaltrialsin-depthresearchrequiredimprovebioavailabilitytwoachievedesirableOverallmaybecomepotentialdrugcandidatescombatingdreadfulUnveilingMultifacetedPharmacologicalActionsIndole-3-CarbinolDiindolylmethane:ComprehensiveReviewcruciferousdiindolylmethaneimmunomodulationindole-3-carbinolorgan

Similar Articles

Cited By